The global sacral nerve stimulation market size is expected treach USD 5,334.82 million by 2034, according ta new study by Polaris Market Research. The report “Sacral Nerve Stimulation Market Size, Share, Trends, Industry Analysis Report: By Product Type (Devices and Accessories), Application, End User, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Market Forecast, 2025–2034” gives a detailed insight intcurrent market dynamics and provides analysis on future market growth.
The sacral nerve stimulation market is experiencing significant growth due tadvancements in technology that enhance device effectiveness and affordability. Increased sophistication and cost-effectiveness of sacral nerve stimulation devices are likely tdrive higher adoption rates among healthcare providers and patients. For instance, Medtronic’s launch of the InterStim MicrRechargeable Sacral Neuromodulation System in August 2020 shows innovation in this field, offering better performance and patient convenience. These developments expand treatment options and boost patient confidence, thereby contributing tthe market growth.
The sacral nerve stimulation market is expanding due tthe rising adoption of minimally invasive procedures. For instance, according tthe National Library of Medicine, minimally invasive procedures currently have an adoption rate of 80% t90%. Patients and healthcare providers increasingly prefer less invasive options that offer quicker recovery and fewer complications. This shift in preference has increased the demand for sacral nerve stimulation as an appealing treatment for urinary and fecal incontinence, positively impacting the market expansion.
Rising healthcare expenditure, as a percentage of GDP, is driving the demand for sacral nerve stimulators. This has led tincreased investment in advanced medical technologies, enhancing patient care and treatment options for conditions like urinary and fecal incontinence.
Sacral Nerve Stimulation Market Report Highlights
Based on product type, the device segment is anticipated texperience substantial growth with a significant CAGR in the global market. This growth is attributed tan increase in the adoption of new devices due tminiaturization and enhanced functionality.
Based on end user, the hospitals segment is expected tdominate the global market in the forecasted years, driven by the increase in hospital admissions and extended hospital stays.
In 2024, North America dominated the global sacral nerve stimulation market due tthe increasing number of hospitals in the region.
The sacral nerve stimulation market in Germany is projected for substantial growth due tincreasing government expenditure on healthcare.
A few of the global key market players are Saluda Medical Pty Ltd.; Medtronic plc; Beijing PINS Medical Co., Ltd.; Axonics, Inc.; Boston Scientific Corporation; NervCorp.; Stimwave Technologies Inc.; St. Jude Medical; and Congentix Medical.
Polaris Market Research has segmented the sacral nerve stimulation market research report on the basis of product type, application, end user, and region:
By Product Type Outlook (Revenue – USD Million, 2020–2034)
Devices
Accessories
By Application Outlook (Revenue – USD Million, 2020–2034)
Urinary and Fecal Incontinence
Chronic Anal Fissure
Urge Incontinence
Others
By End User Outlook (Revenue – USD Million, 2020–2034)
Hospitals
Speciality Clinics
Others
By Regional Outlook (Revenue – USD Million, 2020–2034)
North America
US
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
Australia
Rest of Asia Pacific
Latin America
Argentina
Brazil
Mexic
Rest of Latin America
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
Rest of Middle East & Africa
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook